Aveir DR i2i

Purpose of Study

This clinical investigation is intended to evaluate the dafety and effectiveness of the AveirTM Dual-Chamber (DR) Leadless Pacemaker (LP) system.

Trial Status

Closed, FDA Approved

Eligibility Criteria

Must be 18 years of age, life expectancy of at least 1 year, willing to comply with procedures and required follow-up visits, tests, and exams

Duration of Participation

Approxmiately 12-20 months

Contact Name: Rachel Hackett, RN

Contact Phone: 515-633-3845

Contact Email: rachel.hackett@mercyoneiowa.org